norethindrone acetate

Adult Dosing .

Dosage forms:  TAB: 5 mg

amenorrhea, secondary

[2.5-10 mg PO qd x5-10 days]

Info: give during 2nd half of theoretical menstrual cycle

abnormal uterine bleeding

[acute phase (off-label)]

Dose: 5-10 mg PO tid x7 days

[maintenance phase]

Dose: 2.5-10 mg PO qd x5-10 days; Info: give during 2nd half of theoretical menstrual cycle

endometriosis

[15 mg PO qd]

Start: 5 mg PO qd x2wk, then incr. by 2.5 mg/day q2wk

renal dosing

[see below]

renal impairment: not defined, caution advised

HD/PD: not defined

hepatic dosing

[see below]

hepatic impairment/disease: contraindicated

Peds Dosing .

Dosage forms:  TAB: 5 mg

abnormal uterine bleeding (off-label)

[acute phase, postmenarchal patients]

Dose: 5-10 mg PO tid x7 days

[maintenance phase, postmenarchal patients]

Dose: 2.5-10 mg PO qd x5-10 days; Info: give during 2nd half of theoretical menstrual cycle

renal dosing

[not defined]

renal impairment: consider adult renal dosing for guidance

HD/PD: not defined

hepatic dosing

[not defined]

hepatic impairment: consider adult hepatic dosing for guidance